pharma
Valeant begins long comeback trail with FDA approval
November 6, 2017Sales and Marketing Valeant, Vyzulta, biotech, drugs, pharma, pharmaceutical
Valeant has had precious little to be happy about over the last few years, it’s bounced from one piece of …
Gut bacteria may be key to efficacy of immunotherapies
November 6, 2017Research and Development, Sales and Marketing biotech, drugs, immunotherapy, pharma, pharmaceutical
Why immunotherapies are successful in some individuals and not in others is a matter of huge importance to both patients …
NHS to offer GP appointments via smartphone
November 6, 2017Medical Communications, Sales and Marketing GP at hand, NHS, biotech, drugs, pharma, pharmaceutical
It has been announced that I trial will begin in London offering the public GP consultations through their smartphone. The …
Novartis aims for CAR-T double-approval in Europe
November 6, 2017Sales and Marketing CAR-T, Gilead, Juno, Novartis, biotech, drugs, pharma, pharmaceutical
Just last week Novartis revealed it had applied to the FDA for a new indication in diffuse large B-cell lymphoma …
Top Ten most popular articles on Pharmafile.com this week
November 3, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing drug, pharma, pharmaceuticals, top ten
As we move into November, we bring you another run down of the top ten most popular articles on Pharmafile.com …
GSK’s R&D head to move on after shift in focus
November 3, 2017Medical Communications GSK, biotech, drugs, pharma, pharmaceutical
There has been a raft of changes at senior levels of GSK since Emma Walmsley took over the role from …
Witty to lead way in fast-tracking medicine through UK system
November 3, 2017Medical Communications AAR, Andrew Witty, GSK, biotech, drugs, pharma, pharmaceutical
The UK government has announced its response to the Accelerated Access Review that was published last year, with former GSK …
GSK’s experimental multiple myeloma scores Breakthrough designation with FDA
November 3, 2017Medical Communications, Research and Development, Sales and Marketing Cancer, FDA, GSK, GlaxoSmithKline, multiple myeloma, pharma
GlaxoSmithKline is celebrating the FDA’s decision to award its experimental therapy GSK2857916 with Breakthrough Therapy Designation as a monotherapy in …
Teva’s woes continue, as shares sink to 17-year low on Q3 results
November 2, 2017Medical Communications Mylan, Teva, biotech, drugs, pharma, pharmaceutical
Spare a thought for Kare Schultz, he agreed to take on the position of CEO at Teva at the start …
Tissue Regenix promotes new CEO from within
November 2, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical, tissue regenix
Just over two weeks ago, Tissue Regenix announced that its long-standing CEO, Antony Odell, would be leaving the company. It …
FDA issues warnings in crackdown on baseless cannabis miracle cures
November 2, 2017Research and Development, Sales and Marketing FDA, cannabidiol, cannabis, pharma
The FDA has issued a warning over cannabis-based therapies which promise the ability to cure cancer, asserting that such treatments …
Sanofi Q3 results disappoint due to waning diabetes sales
November 2, 2017Sales and Marketing Lantus, Sanofi, diabetes, pharma
Sanofi readjusted its 2017 financial expectations after its third-quarter results came in lower than projected. The company revealed that net …
New test could determine womens’ risk of miscarriage or premature birth
November 2, 2017Research and Development biotech, drugs, pharma, pharmaceutical, pregnancy
Scientists in the US have reported findings suggesting that certain molecules in the blood are strongly associated with complications during …
Allergan ready to take a loss by selling Teva shares
November 2, 2017Sales and Marketing Allergan, Mylan, Teva, biotech, drugs, pharma, pharmaceutical
Allergan sold its generic business to Teva back in August 2016 for a sum of $33 billion and 100 million …
Novartis reveals the data behind its showdown with Gilead
November 1, 2017Research and Development CAR-T, Gilead, Kymriah, Novartis, biotech, drugs, pharma, pharmaceutical
Only yesterday it was revealed that Novartis had applied to the FDA in the same indication that Gilead’s treatment is …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
